Cargando…

678. Rapid Molecular SARS-CoV-2 Detection by Abbott ID NOW Is Reliable in Pediatric Patients

BACKGROUND: The COVID-19 Pandemic demonstrated the importance of rapid, accurate, point of care testing to control spread of the virus. The availability of this testing has been crucial to re-opening schools, keeping children safely in schools, and returning children to school quickly following illn...

Descripción completa

Detalles Bibliográficos
Autores principales:	Murphy, Catherine, Scarcello, Emily Sheboy, Nolan, Sheila M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Poster Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644400/ http://dx.doi.org/10.1093/ofid/ofab466.875

Ejemplares similares

Comparison of Cepheid Xpert Xpress and Abbott ID Now to Roche cobas for the Rapid Detection of SARS-CoV-2
por: Smithgall, Marie C., et al.
Publicado: (2020)

Diagnostic accuracy of the Abbott ID NOW SARS-CoV-2 rapid test for the triage of acute medical admissions
por: Barnacle, J.R., et al.
Publicado: (2022)

Performance of the Abbott ID NOW rapid SARS-CoV-2 amplification assay in relation to nasopharyngeal viral RNA loads
por: Sepulveda, Jorge L., et al.
Publicado: (2021)

Abbott ID NOW™ COVID-19 assay: do not discard the swab
por: MacDonald, Clayton, et al.
Publicado: (2023)

One swab, two tests: Validation of dual SARS-CoV-2 testing on the Abbott ID NOW™
por: Burnes, Laura E, et al.
Publicado: (2021)

Abbott ID now COVID-19 assay performance: a year in review
por: Thwe, Phyu M., et al.
Publicado: (2021)

Comparison of Abbott ID Now and Abbott m2000 Methods for the Detection of SARS-CoV-2 from Nasopharyngeal and Nasal Swabs from Symptomatic Patients
por: Harrington, Amanda, et al.
Publicado: (2020)

Application of Abbott ID NOW in the emergency department for SARS-CoV-2 detection: A medical center’s perspective
por: Fan, Shu-Ling
Publicado: (2023)

Evaluating the Ability to ID (COVID-19) NOW: a Large Real-World Prospective Evaluation of the Abbott ID NOW COVID-19 Assay
por: Barker, K. R., et al.
Publicado: (2022)

Acceptable performance of the Abbott ID NOW among symptomatic individuals with confirmed COVID-19
por: Stokes, William, et al.
Publicado: (2021)

Multi-site point of care assessment of Abbott ID NOW rapid molecular test for SARS-CoV-2 in a low-prevalence setting
por: Graham, Maryza, et al.
Publicado: (2021)

A brief performance evaluation and literature review of Abbott ID Now COVID-19 rapid molecular-based test
por: Aupaix, Antoine, et al.
Publicado: (2021)

Comparison of abbott ID NOW COVID-19 rapid molecular assay to cepheid xpert xpress SARS-CoV-2 assay in dry nasal swabs
por: Serei, Virian D., et al.
Publicado: (2021)

Performance of Abbott ID‐Now rapid nucleic amplification test for laboratory identification of COVID‐19 in asymptomatic emergency department patients
por: Ramachandran, Anu, et al.
Publicado: (2021)

Comparison of Abbott ID NOW, a novel isothermal amplification based COVID-19 diagnostic method with RTPCR
por: Srivastava, Smriti, et al.
Publicado: (2022)

Detection of the Omicron Variant Virus With the Abbott BinaxNow SARS-CoV-2 Rapid Antigen Assay
por: Regan, James, et al.
Publicado: (2022)

366. Abbott BinaxNOW Rapid Antigen Test Performance in Detecting SARS-CoV-2 Infections in a COVID-19 Outbreak Among Horse Racetrack Workers
por: Surasi, Krishna, et al.
Publicado: (2021)

Assessment of the Abbott BinaxNOW SARS-CoV-2 rapid antigen test against viral variants of concern
por: Rao, Anuradha, et al.
Publicado: (2022)

Abbott® ID NOW™ COVID-19 rapid molecular assay versus Hologic® Panther Aptima™ SARS-CoV-2 assay in nasopharyngeal specimens: results from 1-year retrospective study in an emergency department
por: Bousquet, Aurore, et al.
Publicado: (2022)

Comparative Evaluation of Cartridge-Based Abbott ID NOW Test With Probe-Based Real-Time Reverse Transcription Polymerase Chain Reaction Assay for Detection of SARS-CoV-2
por: Pattnaik, Dipti, et al.
Publicado: (2022)

Prospective population-level validation of the Abbott ID NOW severe acute respiratory syndrome coronavirus 2 device implemented in multiple settings for testing asymptomatic and symptomatic individuals
por: Stokes, William, et al.
Publicado: (2023)

Evaluation of the Abbott BinaxNOW rapid antigen test for SARS-CoV-2 infection in children: Implications for screening in a school setting
por: Sood, Neeraj, et al.
Publicado: (2021)

Implementation of the Abbott ID Now COVID-19 assay at a tertiary care center: a prospective pragmatic implementation study during the third wave of SARS-CoV-2 in Ontario
por: Deslandes, Vincent, et al.
Publicado: (2022)

Evaluation of Abbott ID NOW COVID-19 POC test performance characteristics and integration in the regional health network workflows to improve health care delivery
por: Babic, N., et al.
Publicado: (2023)

P678: EARLY WARNING RESPONSES IN CML PATIENTS: A REAL-LIFE TURIN EXPERIENCE
por: Giai, Valentina, et al.
Publicado: (2023)

678. Polymorphic Locus Sequence Typing for Pseudomonas aeruginosa Outbreak Detection and Investigation
por: Edlind, Tom
Publicado: (2020)

Analytical Sensitivity of the Abbott BinaxNOW COVID-19 Ag Card
por: Perchetti, Garrett A., et al.
Publicado: (2021)

P441 – P678
Publicado: (2006)

Fast and reliable real life data on COVID-19 triaging with ID NOW
por: Burdino, Elisa, et al.
Publicado: (2022)

Effectiveness of Abbott BinaxNOW Rapid Antigen Test for Detection of SARS-CoV-2 Infections in Outbreak among Horse Racetrack Workers, California, USA
por: Surasi, Krishna, et al.
Publicado: (2021)

Comparison of Abbott ID Now, DiaSorin Simplexa, and CDC FDA Emergency Use Authorization Methods for the Detection of SARS-CoV-2 from Nasopharyngeal and Nasal Swabs from Individuals Diagnosed with COVID-19
por: Rhoads, Daniel D., et al.
Publicado: (2020)

Sensitive on-site detection of SARS-CoV-2 by ID NOW COVID-19
por: Krause, Eva, et al.
Publicado: (2021)

Performance of Abbott ID Now COVID-19 Rapid Nucleic Acid Amplification Test Using Nasopharyngeal Swabs Transported in Viral Transport Media and Dry Nasal Swabs in a New York City Academic Institution
por: Basu, Atreyee, et al.
Publicado: (2020)

QR678 & QR678 Neo Hair Growth Formulations: A Cellular Toxicity & Animal Efficacy Study
por: Kapoor, Rinky, et al.
Publicado: (2020)

Sensitivity of ID NOW and RT–PCR for detection of SARS-CoV-2 in an ambulatory population
por: Tu, Yuan-Po, et al.
Publicado: (2021)

SAT678 Metabolic Disorders In Thalidomide Embryopathy
por: Tanabe, Akiyo
Publicado: (2023)

424. Sensitivity Results for the Abbott m2000 PCR Assay of SARS-CoV-2 at a Denver, Colorado Medical Center
por: Aragon, Deborah, et al.
Publicado: (2020)

418. Comparison of the Abbott SARS-CoV-2 IgG and DiaSorin LIASON SARS-CoV-2 S1/S2 IgG Antibody Assays
por: Schaack, Grace A, et al.
Publicado: (2020)

Evaluation of Abbott BinaxNOW Rapid Antigen Test for SARS-CoV-2 Infection at Two Community-Based Testing Sites — Pima County, Arizona, November 3–17, 2020
por: Prince-Guerra, Jessica L., et al.
Publicado: (2021)

Evaluation of the Abbott BinaxNOW COVID-19 Test Ag Card for rapid detection of SARS-CoV-2 infection by a local public health district with a rural population
por: Pollreis, Rachel E., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_5mo1u8127tf6b46url9fb9ptk7